Ozempic effective for patients with chronic kidney damage

In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic kidney disease and obesity.

VCTE-Based Agile Scores Accurate in Predicting Liver-Related Events in MASLD

The use of Agile scores based on vibration-controlled transient elastography (VCTE) accurately predicted liver-related events in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according

March 26, 2024

FDA misses target date for releasing rules to make pulse oximeters more equitable

New guidelines to force device manufacturers to make pulse oximeters more equitable for patients with darker skin have not been released by the Food and

October 1, 2024

Medable & Pluto Health Partner to Increase Patient Access to Clinical Trials

What You Should Know: – Medable Inc., a technology provider for modern clinical trials forms an enterprise partnership with Pluto Health, a smart care coordination

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.